rs121908164
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001365951.3(KIF1B):c.4580G>A(p.Ser1527Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. S1527S) has been classified as Likely benign.
Frequency
Consequence
NM_001365951.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIF1B | NM_001365951.3 | c.4580G>A | p.Ser1527Asn | missense_variant | Exon 43 of 49 | ENST00000676179.1 | NP_001352880.1 | |
KIF1B | NM_001365952.1 | c.4580G>A | p.Ser1527Asn | missense_variant | Exon 43 of 49 | NP_001352881.1 | ||
KIF1B | NM_015074.3 | c.4442G>A | p.Ser1481Asn | missense_variant | Exon 41 of 47 | NP_055889.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152126Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251448Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135912
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461894Hom.: 0 Cov.: 34 AF XY: 0.00000688 AC XY: 5AN XY: 727248
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152126Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.S1481N variant (also known as c.4442G>A), located in coding exon 40 of the KIF1B gene, results from a G to A substitution at nucleotide position 4442. The serine at codon 1481 is replaced by asparagine, an amino acid with highly similar properties. This alteration has been identified in a patient with multiple tumors of the neural crest (neuroblastoma, ganglioneuroma and leiomyosarcoma) in addition to bilateral pheochromocytoma (Schlisio S et al. Genes Dev., 2008 Apr;22:884-93; Yeh IT et al. Hum. Genet., 2008 Oct;124:279-85). The variant was also identified in her paternal grandfather who also had bilateral pheochromocytoma and in father who had a lung adenocarcinoma (Yeh IT et al. Hum. Genet., 2008 Oct;124:279-85). None of the neural tumors had loss of heterozygosity, however the lung adenocarcinoma did (Yeh IT et al. Hum. Genet., 2008 Oct;124:279-85). Functional analysis indicates that although this variant is able to stimulate DHX9 nuclear localization, the apoptosis that normally ensues is significantly impaired (Schlisio S et al. Genes Dev., 2008 Apr;22:884-93; Fell SM et al. Genes Dev., 2017 05;31:1036-1053). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Charcot-Marie-Tooth disease type 2 Uncertain:1
This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 1481 of the KIF1B protein (p.Ser1481Asn). This variant is present in population databases (rs121908164, gnomAD 0.002%). This missense change has been observed in individual(s) with clinical features of autosomal dominant KIF1B-related conditions (PMID: 18726616, 33112832). ClinVar contains an entry for this variant (Variation ID: 4662). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change affects KIF1B function (PMID: 18334619). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
NEUROBLASTOMA, SUSCEPTIBILITY TO, 1, INCLUDED Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at